High incidence of donor-reactive delayed-type hypersensitivity reactivity in transplant patients

American Journal of Transplantation

Volumn 2, Issue 10, 2002, Pages 926-933

  Pelletier, Ronald P ^a   Hennessy, Patrice K ^a   Adams, Patrick W ^a   Orosz, Charles G ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Alloantibodies; Clinical outcome; Donor reactive DTH; Kidney; Simultaneous kidney pancreas; Transplantation

Indexed keywords

ALLOANTIBODY;

ADULT; ARTICLE; COHORT ANALYSIS; DELAYED HYPERSENSITIVITY; FEMALE; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PANCREAS TRANSPLANTATION; SENSITIZATION; TREATMENT OUTCOME;

ACUTE DISEASE; CONTINENTAL POPULATION GROUPS; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; T-LYMPHOCYTES; TISSUE DONORS; UNITED STATES;

EID: 0344837780     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.21008.x     Document Type: Article

References (27)

1. Rush DN, Karpinski ME, Nickerson P, Dancea S, Birk P, Jeffery JR. Does subclinical rejection contribute to chronic rejection in renal transplant patients? Clin Transplant 1999; 13: 441-446.
2. Purkerson J, Isakson P. A two-signal model for regulation of immunoglobulin isotype switching. FASEB J 1992; 6: 3245-3252.
3. Sirak J, Orosz C, Wakely E, VanBuskirk A. Alloreactive delayed-type hypersensitivity in graft recipients. Transplantation 1997; 63: 1300-1307.
4. VanBuskirk A, Wakely E, Sirak J, Orosz C. Patterns of allosensitization in allograft recipients: long term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive DTH. Transplantation 1998; 65: 1115-1123.
5. Carrodeguas L, Orosz CG, Waldman WJ, Sedmak DD, Adams PW, VanBuskirk AM. Transvivo analysis of human-delayed type hypersensitivity reactivity. Hum Immunol 1999; 60: 640-651.
6. Heeger PS, Greenspan NS, Kuhlenschmidt S et al. Pretransplant frequency of donor-specific, IFN-g-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999; 163: 2267-2275.
7. Baxter-Lowe LA, Eckels DD, Ash R, Casper J, Hunter JB, Gorski J. The predictive value of HLA-DR oligotyping for MLC responses. Transplantation 1992; 53: 1352-1357.
8. Sonoda Y, Sano Y, Ksander B, Streilein J. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice. Invest Ophthalmol Visual Sci 1995; 36: 427-434.
9. Lechler R, Heaton T, Barber L, Bal V, Batchelor J, Lombardi G. Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses. Immunol Lett 1992; 34: 63-69.
10. Benoist C, Mathis D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nature Immunol 2001; 2: 797-801.
11. Hahn H, Kaufmann SH, Falkenberg F, Chahinin M, Horn W. Peritoneal exudate T lymphocytes with specificity to shepp red blood cells. II. Inflammatory helper T cells and effector T cells in mice with delayed-type hypersensitivity and in suppressed mice. Immunology 1979; 38: 51-55.
12. Milon G, Marchal G, Seman M, Truffa-Bachi P, Zilberfarb V. Is the delayed-type hypersensitivity observed after a low dose of antigen mediated by helper T cells? J Immunol 1983; 130: 1103-1107.
13. Vella JP, Vos L, Carpenter CB, Sayegh MH. Role of indirect allorecognition in experimental late acute rejection. Transplantation 1997; 64: 1823-1828.
14. Monteiro F, Buelow R, Mineiro C, Rodrigues H, Kalil J. Identification of patients at high risk of graft loss by pre-and posttransplant monitoring of anti-HLA class I IgG antibodies by enzyme-linked immunosorbent assay. Transplantation 1997; 63: 542-546.
15. Christiaans MH, Nieman F, van Hooff JP, van den Berg-Loonen EM. Detection of HLA class I and II antibodies by ELISA and complement-dependent cytotoxicity before and after transplantation. Transplantation 2000; 69: 917-927.
16. McKenna RM, Takemoto SK, Terasak PI. Anti HLA antibodies after solid organ transplantation. Transplantation 2000; 69: 319-326.
17. Martin S, Mallick N, Gokal R, Harris R, Johnson R. Posttransplant antidonor lymphocytotoxic antibody production in relation to graft outcome. Transplantation 1987; 44: 50-53.
18. Scornik JC, Lim P, Howard R, Pfaff W. Posttransplant antidonor antibodies and graft rejection. Transplantation 1989; 47: 287-290.
19. Suciu-Foca N, Reed E, D'Agati VD et al. Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients. Transplantation 1991; 51: 593-601.
20. Halloran PF, Schlaut J, Solez K, Srinivasa NS. The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation 1992; 53: 550-555.
21. al-Hussein KA, Shenton BK, Bell A et al. Characterization of donor-directed antibody class in the post-transplant period using flow cytometry in renal transplantation. Transplant Int 1994; 7: 182-189.
22. Lobo PI, Spencer CE, Stevenson WC, Pruett TL. Evidence demonstrating poor kidney graft survival when acute rejections are associated with IgG donor-specific lymphocytotoxin. Transplantation 1995; 59: 357-360.
23. Trpkov K, Campbell P, Pazderka F, Cockfield S, Solez K, Halloran P. Pathologic features of acute renal allograft rejection associated with donor-specific antibody: analysis using the Banff grading schema. Transplantation 1996; 61: 1586-1592.
24. Abe M, Kawai T, Futatsuyama K et al. Postoperative production of antidonor antibody and chronic rejection in renal transplantation, Transplantation 1997; 63: 1616-1619.
25. Schonemann CGJ, Leverenz S, May G. HLA class I and class II antibodies. Transplantation 1998; 65: 1519-1523.
26. Piazza A, Adorno D, Poggi E et al. Flow cytometry crossmatch. A sensitive technique for assessment of acute rejection in renal transplantation. Transplant Proc 1998; 30: 1769-1771.
27. Christiaans MHL, Overhof-De Roos R, Nieman F, Van Hooff JP, Van Den Berg-Loonen E. Donor-specific antibodies after transplantation by flow cytometry: relative change in fluorescence ratio most sensitive risk factor for graft survival. Transplantation 1998; 65: 427-433.